Dawn is Reata’s Chief Commercial Officer and leads marketing, market access, sales, training, and commercial operations. She joined Reata in September 2016. Prior to joining Reata, Dawn served as Vice President of Sales with Pharmacyclics, LLC, where she built and led their first hematology national sales organization of sales representatives, division managers, and regional sales directors, and was responsible for the launch of IMBRUVICA in the United States and Puerto Rico. Before that, Dawn served as Vice President of Sales & Marketing with McKesson US Pharmaceutical, SKY Pharmaceuticals, and RxPak. She held positions of increasing responsibility within McKesson Corporation, Genentech, Inc., and Bristol-Myers Squibb Company. Dawn holds a B.S. in Biology from Binghamton University.